ACADIA Pharmaceuticals is trading at $21.42, up 4.13%, in a strong broader-market session and amid an active biotech rally. - The supplied market context puts XBI up 2.13%, alongside gains in major U.S. indexes. - No company-specific announcement explaining the intraday rise was found. - ACADIA was scheduled to report third-quarter results after the November 4 market close; that scheduled report is context, not a confirmed explanation for the move.